HDAC9 and neoplasm: HDAC inhibitors cause a variety of antiproliferative effects in transformed and tumor cells, like cell cycle arrest, autophagy, senescence [6,7], cell death (apoptosis), and differentiation depending on the cellular context, as well as in the mutations that caused the particular malignant transformation [8].